Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.36
BATS BZX Real-Time Price
As of 12:24pm ET
 +0.01 / +0.74%
Today’s Change
1.19
Today|||52-Week Range
2.00
-2.16%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close1.35
Today’s open1.36
Day’s range1.32 - 1.37
Volume681,017
Average volume (3 months)1,261,527
Market cap$259.8M
Dividend yield--
Data as of 12:09pm ET, 04/28/2015

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-36.36%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales10.03
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc+0.10+1.64%
CARACara Therapeutics In...-0.02-0.17%
POZNPOZEN Inc+0.11+1.33%
AGRXAgile Therapeutics I...-0.38-3.14%
Data as of 12:22pm ET, 04/28/2015

Financials

Next reporting dateJuly 13, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers